WallStSmart

Cardinal Health Inc (CAH)vs111 Inc (YI)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Cardinal Health Inc generates 1701% more annual revenue ($244.67B vs $13.58B). CAH leads profitability with a 0.7% profit margin vs -0.5%. CAH earns a higher WallStSmart Score of 53/100 (C-).

CAH

Buy

53

out of 100

Grade: C-

Growth: 7.3Profit: 4.5Value: 8.7Quality: 5.8
Piotroski: 4/9Altman Z: 4.30

YI

Avoid

31

out of 100

Grade: F

Growth: 4.0Profit: 2.0Value: 5.0Quality: 7.5
Piotroski: 5/9Altman Z: 3.45
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

CAHUndervalued (+14.8%)

Margin of Safety

+14.8%

Fair Value

$263.37

Current Price

$211.31

$52.06 discount

UndervaluedFair: $263.37Overvalued

Intrinsic value data unavailable for YI.

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

CAH2 strengths · Avg: 9.0/10
Altman Z-ScoreHealth
4.3010/10

Safe zone — low bankruptcy risk

Revenue GrowthGrowth
18.8%8/10

18.8% revenue growth

YI2 strengths · Avg: 10.0/10
Debt/EquityHealth
-0.3010/10

Conservative balance sheet, low leverage

Altman Z-ScoreHealth
3.4510/10

Safe zone — low bankruptcy risk

Areas to Watch

CAH4 concerns · Avg: 3.3/10
P/E RatioValuation
29.8x4/10

Moderate valuation

Return on EquityProfitability
0.0%3/10

ROE of 0.0% — below average capital efficiency

Profit MarginProfitability
0.7%3/10

0.7% margin — thin

Operating MarginProfitability
1.2%3/10

Operating margin of 1.2%

YI4 concerns · Avg: 2.8/10
EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$58.07M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
-10.9%2/10

ROE of -10.9% — below average capital efficiency

Revenue GrowthGrowth
-16.7%2/10

Revenue declined 16.7%

Comparative Analysis Report

WallStSmart Research

Bull Case : CAH

The strongest argument for CAH centers on Altman Z-Score, Revenue Growth. Revenue growth of 18.8% demonstrates continued momentum. PEG of 1.33 suggests the stock is reasonably priced for its growth.

Bull Case : YI

The strongest argument for YI centers on Debt/Equity, Altman Z-Score.

Bear Case : CAH

The primary concerns for CAH are P/E Ratio, Return on Equity, Profit Margin. Thin 0.7% margins leave little buffer for downturns.

Bear Case : YI

The primary concerns for YI are EPS Growth, Market Cap, Return on Equity.

Key Dynamics to Monitor

CAH profiles as a growth stock while YI is a turnaround play — different risk/reward profiles.

YI carries more volatility with a beta of 0.64 — expect wider price swings.

CAH is growing revenue faster at 18.8% — sustainability is the question.

CAH generates stronger free cash flow (555M), providing more financial flexibility.

Bottom Line

CAH scores higher overall (53/100 vs 31/100) and 18.8% revenue growth. Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Cardinal Health Inc

HEALTHCARE · MEDICAL DISTRIBUTION · USA

Cardinal Health, Inc. is an American multinational health care services company.

Visit Website →

111 Inc

HEALTHCARE · MEDICAL DISTRIBUTION · China

111, Inc. operates an integrated online and offline platform in the healthcare market in the People's Republic of China. The company is headquartered in Shanghai, the People's Republic of China.

Visit Website →

Want to dig deeper into these stocks?